Filter
373
Text search:
pharmacology
Featured
Recommendations
34
New Publications
79
Language
Document type
No document type
192
Studies & Reports
73
Guidelines
68
Manuals
17
Training Material
7
Situation Updates
4
Fact sheets
4
Strategic & Response Plan
3
Resource Platforms
2
Online Courses
2
Brochures
1
Countries / Regions
India
32
South Africa
14
Ethiopia
10
Global
9
Africa
8
Nigeria
7
Nepal
6
Kenya
5
Rwanda
5
Bangladesh
5
Western and Central Europe
5
Russia
5
Uganda
4
Syria
4
Brazil
4
Latin America and the Carribbean
4
Sierra Leone
3
Ghana
3
Mozambique
3
Namibia
3
Eswatini/ Swaziland
3
Ukraine
3
Angola
3
Lesotho
3
Myanmar / Burma
3
Burkina Faso
2
Liberia
2
Congo, Democratic Republic of
2
Guinea-Bissau
2
USA
2
Zimbabwe
2
Germany
2
Zambia
2
Tanzania
2
Indonesia
2
Malawi
2
Argentina
2
Botswana
2
Eastern Europe
2
Haiti
1
Philippines
1
South Sudan
1
Iraq
1
Thailand
1
China
1
Sudan
1
Ecuador
1
Bolivia
1
East and Southern Africa
1
Paraguay
1
Asia
1
Mongolia
1
Southern Africa
1
Canada
1
Tajikistan
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
126
Clinical Guidelines
42
Public Health
17
Women & Child Health
8
Pharmacy & Technologies
7
Capacity Building
3
Key Resources
1
Toolboxes
Pharmacy
51
Mental Health
45
AMR
33
TB
25
HIV
24
COVID-19
21
Caregiver
12
NTDs
12
NCDs
12
Conflict
7
Specific Hazards
5
Ebola
4
Disability
3
Planetary Health
3
Natural Hazards
2
AUDIT REPORT NO. 9-000-11-001-P | February 24, 2011
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an
...
Accessed November, 2017
Drug Advisory Board
Document No. : FDA/SMC/SMD/GL-RAR/2013/01
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
Division of Tuberculosis Elimination.
Therapeutics Information and Pharmacovigilance Centre | TIPC
STATUTORY INSTRUMENTS | SUPPLEMENT No. 8 28th March, 2014 | STATUTORY INSTRUMENTS SUPPLEMENT | to The Uganda Gazette No. 18 Volume CVII dated 28th March, 2014 | Printed by UPPC, Entebbe, by Order of the Government. | STATUTORY INSTRUMENTS | 2014 No. 29.
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
Lessons from the STEP-TB Project.
Accessed November 2017.
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo
...
Improving the management of childhood tuberculosis within national tuberculosis programmes: research priorities based on a literature review
WHO/HTM/TB/2007.381, 07.02
Eine Leitlinie zur Diagnostik und Therapie, einschließlich Chemoprävention und -prophylaxe des Deutschen Zentralkomitees zur Bekämpfung der Tuberkulose e.V. im Auftrag der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V.
Tuberculosis Guideline for Adults
Guideline for Diagnosis
...